Skip to Main Content

Paper Details

Small molecule inhibition of deubiquitinating enzyme JOSD1 as a novel targeted therapy for leukemias with mutant JAK2.
Leukemia
11
2022
Author NameAffiliation
Eric P WinerDana-Farber Cancer Institute
Eric P WinerHarvard Medical School
Richard M StoneDana-Farber Cancer Institute
Richard M StoneHarvard Medical School
  • 1 - 4

Datasets

Release 1.2